Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the pharmacokinetics of AL-60371 otic suspension
following two posologies of bilateral ototopical doses in pediatric subjects immediately
after bilateral tympanostomy tube surgery.